ロード中...
The Surge in the Number of Circulating Tumor Cells Following Treatment with Sunitinib for Metastatic Renal Cell Carcinoma
Circulating tumor cells (CTCs) are a promising biomarker for several cancers. We streamlined the experimental procedure of CTC immunofluorescent staining. We encountered a 72-year-old woman with metastatic right renal cell carcinoma (RCC) (clinical stage: T4N0M1), whose CTC number rapidly increased...
保存先:
| 出版年: | Intern Med |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The Japanese Society of Internal Medicine
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6191600/ https://ncbi.nlm.nih.gov/pubmed/29709937 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.0663-17 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|